Background: In recent years, many factors have revamped the interest in segmentectomies as preferred procedure for stage I non-small cell lung cancer (NSCLC). The aim of this systematic review and metaanalysis is to compare the outcomes of segmentectomy versus lobectomy regarding overall survival (OS) in the surgical treatment of stage I NSCLC, as stated in the conclusions of the largest studies conducted in this field and reported to date.
Introduction
Traditionally, the management of patients with stage I non-small cell lung cancer (NSCLC) includes lobectomy associated to complete lymph node dissection through a conventional thoracotomy or thoracoscopic approach.
Conversely, sublobar resections are considered the treatment of choice in patients with a compromised cardiorespiratory status (1) .
In recent years, along with the line of what already happened in breast surgery, many factors have revamped the interest in sublobar resections, segmentectomies Original Article Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis in particular, as preferred procedures for early lung cancers. In fact, with the technical advances in thoracic imaging and the use of low-dose computed tomography in screening programs as well as more accurate patient selection strategies, thoracic surgeons will likely encounter a significant increase in the number of small peripheral lesions in clinical practice (2) .
The main advantage of the segmentectomy over lobectomy is that it is an anatomical resection with a parenchyma sparing-effect. However, whether anatomic segmentectomy is comparable with lobectomy about oncologic outcomes in patients with stage I disease is still debated in the medical and surgical community. The aim of this systematic review and meta-analysis is to compare the results of segmentectomy versus lobectomy regarding overall survival (OS) in the surgical treatment of early stage (stage I) NSCLC, as stated in the conclusions of the largest studies conducted in this field and reported and reported to date.
Methods

Search strategy and selection criteria
A search strategy using a combination of free-text words, relevant MeSH terms and appropriate filters was designed; the searching strategy was developed in EMBASE (via Ovid), MEDLINE (via PubMed) and Cochrane CENTRAL from 1990 until December 2016, without imposing any language or time restrictions (see section "Search history" in Supplementary). Records identified through our search strategy were imported into reference management software. The eligibility criteria were: stage I NSCLC patients; segmentectomy without wedge resection; comparison of recurrence-free survival, OS between lobectomy and segmentectomy. Two authors worked independently to assess each identified study based on the eligibility criteria; when multiple studies contained overlapping data, a most informative study was included. Letters, editorials, case reports, and reviews were excluded. Disagreements were discussed and resolved by consensus. Data extracted included study characteristics, baseline patient characteristics primary and secondary outcomes. We selected papers in the meta-analysis that also included wedge resections, but only when the OS was distinguished in the two groups of surgical techniques of sublobar resection (wedge and segmentectomy). The Cochrane's Collaboration Tool was used to assess the risk of bias for the primary outcome for included studies (3) . The risk of bias due to incomplete outcome data was evaluated at an outcome level, while the risk of bias due to sequence generation, allocation concealment, blinding, selective reporting or funding was assessed at study level. The risk of bias was assessed by two independent reviewers and disagreements were settled by discussion and consensus [see section "Risk of bias assessment of the primary outcome (immediate success)" in Supplementary]. Details of the protocol for this systematic review were registered on PROSPERO and can be accessed at http://www.crd.york. ac.uk/prospero/display_record.asp?ID=CRD42016040153. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement was used to improve the report of this systematic review (Table S1 ) (4) .
Data analysis
The meta-analysis was performed by combining the reported survival outcomes of the individual studies using a random effect model. The OS of the lobectomy group was compared with the segmentectomy group alone. The hazard ratio (HR) and standard error were extracted or calculated from each study using Kaplan-Meier graphs with methods reported in the literature (5, 6) . Confidence intervals (CI) were set to 95%. Heterogeneity was measured using χ 2 test and I
2
. Values of P<0.10 or I 2 >50% represented substantial heterogeneity. The publication bias was assessed for the primary outcome with a Funnel plot, both visually and formally with Egger's test (P<0.10 suggests strong asymmetry). Data analysis was performed using Review Manager 5.3 (Nordic Cochrane Centre, Copenhagen, Denmark).
Role of the funding source
There was no source of financing for this study. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
The flow diagram of the study selection process was shown in Figure 1 . The search strategy identified 154 records. Following deduplication, 98 records were screened at the title and abstract level, and six were excluded as irrelevant. The remaining 92 records were assessed in the full text. Of those, 27 were included in the systematic review (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) and meta-analysis (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) .
Baseline characteristics of patients were well balanced in each study. Study characteristics are presented in Table 1 and the quality assessment in Table 2 . Most of these qualified studies were based on the retrospective data. The size of the cohorts varied from 17 to 11,520, with a total number of 24,542 patients. In all HR calculations, the lobectomy was chosen as the reference. None of the included trials was blinded. However, lack of blinding was not considered likely to influence the primary outcome due to its objective nature. Hence, all studies were at low risk of bias despite being open label. Similarly, the risk of bias was low for all other domains. Hence, all trials were at low overall risk of bias. The pooled HR was 1.04 (95% CI, 0.92-1.18; P=0.50). The segmentectomy group was not inferior to patients treated with lobectomy. The Cochrane tests for heterogeneity showed that χ 2 =25.04 degree of freedom =26 (P=0.52); I 2 =0%, which did not suggest a significant inconsistency and heterogeneity between the selected studies. The combined HR displayed in this figure suggested there was no statistical significance between segmentectomy and lobectomy on OS ( Figure 2 ). The funnel plot showed no publication bias ( Figure 3 ). The whole group of papers was then divided in two subgroups regarding the methodology of the study: the first group comprehends the observational studies (24/27), the second the randomized studies (3/27). The HR for retrospective study (HR =1.01; 95% CI, 0.88-1.16, P=0.49) and for randomized clinical trial were not both significant (HR =1.21; 95% CI, 0.89-1.63, P=0.48) (Figures 4 and 5) .
Discussion
The refinement of the diagnostic pathway for NSCLC and the recent consolidation of minimally invasive techniques for lobectomy and segmentectomy have revived the debate about whether segmentectomies should be applied to all patients with early stage NSCLC as intentional resection and not only as compromised procedure in patients with limited cardiopulmonary reserves. To better understand what has been published in the literature until today and to have a current state of the art, we combined data from 26 studies published from 1990 to 2016 and performed Were the characteristics of the included studies provided? 27/27
Was the scientific quality of the included studies assessed and documented? 27/27
Was the scientific quality of the included studies used appropriately in formulating conclusions? 27/27
Were the methods used to combine the findings of studies appropriate? 27/27
Was the likelihood of publication bias assessed? 27/27
Was the conflict of interest stated? 7/27 20/27
NA, not applicable. a meta-analysis by combining the OS in the lobectomy and segmentectomy groups for patients with stage I NSCLC. Overall, the patients in the lobectomy group did not have a better survival than the patients treated with segmentectomy. In particular, a significant benefit of lobectomy over segmentectomy on OS in patients with stage IA disease could not be confirmed.
Other meta-analyses also support these findings. As an example, Cao et al. stated that patients intentionally selected for segmentectomies to treat early-stage, peripheral NSCLC had overall disease-free survival outcomes that were not significantly different to those undergoing lobectomies. Conversely, patients who underwent "compromise" segmentectomies due to medical comorbidities or cardiopulmonary limitations showed a significantly worse OS than lobectomies (34) .
Other published meta-analysis suggested that segmentectomy may not have superior oncologic outcomes for all patients with early stage lung cancer, but only for the subgroups of patients with tumors smaller than 2 cm (35) or for patients in stage IA (36) .
This study presents some limitations. An ideal metaanalysis should be performed using individual patient data, but they may not always be available or practical. Therefore, the majority of meta-analyses are performed using summary data, which is a well-accepted form of analysis.
This study did not include any data about additional chemotherapy or radiotherapy regimens, which might have affected the survival of some patients. Also, since most of the retrospective studies did not describe with accuracy whether the stage was clinical or pathological, it is reasonable to conclude that the authors of the papers subjected to meta-analysis have selected the surgical method mainly based on the clinical stage. Similarly, the comparison between procedures in patients who can tolerate the lobectomy should be more compelling. In fact, most studies did not take into consideration systematic, or sampling lymphadenectomy is emphasising the current technical differences in lymph node management and anatomical approach. In this setting, segmentectomies are more often accompanied by hilar and mediastinal lymph node sampling than dissection (34) .
Another potentially critical issue as a source of bias results from the fact that many studies comparing segmentectomy and lobectomy for stage IA NSCLC did not take into consideration the appearance of the nodule on chest CT, i.e., pure solid, part-solid or pure ground-glass opacity (GGO).
The current meta-analysis disclosed that segmentectomies produce similar survival compared to lobectomy for patients with stage I NSCLC. Considering heterogeneity among studies and most of the data from retrospective studies, the results of the meta-analysis should be interpreted with caution.
More evidence is needed to establish what is the role of segmentectomy in early NSCLC, in particular, a large numbered, prospective, randomised trials, which should dissolve the uncertainties and the questions raised by retrospective data. Otherwise, propensity score matching method is required in a retrospective study, since the patients' selection bias could be incredibly high in such data accumulation.
Currently, two prospective, randomised, multiinstitutional phase III trials are being conducted by the Cancer and Leukemia Group B (CALGB 140503) and the Japan Clinical Oncology Group (JCOG 0802) to establish the effectiveness of intentional sublobar resections for small peripheral tumours (2 cm) (37) (38) (39) . The results will likely provide significant contributions to the role of intentional resection for peripheral stage IA tumours.
In conclusion, our analysis seems to support the concept that rigorously selected patients with early-stage NSCLC may be subjected to segmentectomies rather than lobectomies with similar survival outcomes and the benefit of preserving lung function. 
